Spruce Biosciences Inc reports results for the quarter ended in September - Earnings Summary

Spruce Biosciences

16/11/2021 12:00

* Spruce Biosciences Inc  SPRB.OQ  reported a quarterly adjusted
loss of 49 cents​​ per share for the quarter ended in September.
The mean expectation of four analysts for the quarter was for a
loss of 57 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Spruce Biosciences Inc's reported EPS for the quarter was a
loss of 49 cents​.
* The mean earnings estimate of analysts had fallen by
about 0.9% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Spruce Biosciences Inc shares had fallen by 27.0% this
quarter and lost 82.0% so far this year.
* The company reported a quarterly loss of $11.43 million.
* Wall Street's median 12-month price target for Spruce
Biosciences Inc is $9.50 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 4 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
This summary was machine generated November 16 at 12:00 p.m.
 ​All figures in US dollars unless otherwise stated